Jingrong Jean Cui, Director at Turning Point Therapeutics, Inc. (TPTX), sold 91,000 shares at $44.96 ($4.1M) on 2020-04-07, disclosed to the SEC on 2020-04-08.
Open-market sale of $4.1M TPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.46 | 1,100 | $46K | 1.1% |
| 2 | $42.61 | 2,998 | $128K | 3.1% |
| 3 | $42.61 | 2,998 | $128K | 3.1% |
| 4 | $43.72 | 11,212 | $490K | 12.0% |
| 5 | $43.72 | 11,212 | $490K | 12.0% |
| 6 | $44.22 | 2,890 |
| $128K |
| 3.1% |
| 7 | $44.22 | 2,890 | $128K | 3.1% |
| 8 | $45.13 | 300 | $14K | 0.3% |
| 9 | $43.69 | 4,500 | $197K | 4.8% |
| 10 | $44.96 | 8,100 | $364K | 8.9% |
| 11 | $45.63 | 5,900 | $269K | 6.6% |
| 12 | $45.89 | 6,294 | $289K | 7.1% |
| 13 | $45.89 | 6,294 | $289K | 7.1% |
| 14 | $46.43 | 12,106 | $562K | 13.8% |
| 15 | $46.43 | 12,106 | $562K | 13.8% |
| 16 | $47.23 | 100 | $5K | 0.1% |
| Total | $44.91 avg | 91,000 | $4.1M | 100% |
| Filing → |
| TPTX | SELL | 2020-05-21 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |